naltrexone and glp-1 Successful naltrexone-bupropion treatment after several treatment failures in a patient with severe monogenic obesity: iScience Combining LDN with Microdosing GLP-1

transitioning to full practice authority by Jan 2026 for qualified NPs (but still subject to Corporate Practice of Medicine rules) Key point : Even in collaborative states, NPs can prescribe weight-loss meds you just need the right physician relationship documented

Recently published four-arm target trial which included 283 998 patients compared effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors and sulfonylureas

Diabetologia 64 , 26092652 (2021)

Emerging preclinical research has identified GLP-1 receptors in various immune cells and tissues, leading to scientific interest in potential anti-inflammatory properties